3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
3
Colorectal Neoplasms
2
Breast Diseases
2
Thrombocythemia, Essential
1
Polycythemia Vera
1
Lymphedema
1
Liver Neoplasms
1
Hypogonadism
1
Glioma
1
Fatigue Syndrome, Chronic
1
Eunuchism
1
Adenoma
1
Interventions
fludarabine phosphate
24
Peripheral Blood Stem Cell Transplantation
21
Cyclophosphamide
21
Busulfan
19
Whole-Body Irradiation
15
Tacrolimus
15
Mycophenolic Acid
13
Methotrexate
12
ruxolitinib
11
Cyclosporine
10
Antilymphocyte Serum
10
fludarabine
8
Melphalan
7
peginterferon alfa-2a
6
Aspirin
6
Filgrastim
5
Stem Cell Transplantation
4
Radiotherapy
4
Imatinib Mesylate
4
Hydroxyurea
4
Flow Cytometry
4
Etoposide
4
Decitabine
4
Biopsy
4
Azacitidine
4
Thiotepa
3
Surveys and Questionnaires
3
Prednisone
3
Methylprednisolone
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycythemia Vera
×
Drug Evaluation
×
Clear all
NCT02577926
2025-06-10
Ruxo-BEAT
RWTH Aachen University
Phase 2
Active not recruiting
207 enrolled